Skip to main content

News Archive

News Archive - School of Medicine

$55M NIH Grant Advances Clinical and Translational Research at UC San Diego

May 4, 2020

The Altman Clinical and Translational Research Institute at University of California San Diego has received a five-year, $54.7 million Clinical and Translational Science Award from the National Center for Advancing Translational Science (NCATS), part of the National Institutes of Health.

UC San Diego Health Offers Virtual Appointments to Patients with COVID-19

May 4, 2020

UC San Diego Health now offers a telemedicine clinic to help patients with COVID-19 recover at home.

Clinical Trial to Investigate whether Hypertension Drug Ameliorates COVID-19 Severity

April 30, 2020

UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

UC San Diego Health Nationally Recognized with ‘A’ Grades for Safety

April 30, 2020

UC San Diego Health has been awarded double ‘A’ grades for the spring 2020 Leapfrog Hospital Safety Grade.

Arthritis Drug Presents Promise as Treatment for COVID-19 Pneumonia

April 29, 2020

UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.

Loss of Smell Associated with Milder Clinical Course in COVID-19

April 27, 2020

Researchers at UC San Diego Health report in newly published findings that olfactory impairment suggests the resulting COVID-19 disease is more likely to be mild to moderate, a potential early indicator that could help health care providers determine which patients may require hospitalization.

Gut Microbes Influence How Rat Brains React to Opioids

April 27, 2020

Antibiotic treatment — which depletes gut microbes — drastically changes the parts of a rat’s brain that are activated during opioid addiction and withdrawal.

For ME/CFS Patients, Viral Immunities Come at a Devastating, Lifelong Cost

April 27, 2020

Researchers at UC San Diego School of Medicine and three German universities describe an underlying biological basis for myalgic encephalomyelitis/chronic fatigue syndrome, illustrating how efforts by the body to boost immune system protections can come at physiological cost elsewhere.

Finding Leukemia’s Weakness Using Genome-Wide CRISPR Technology

April 20, 2020

Researchers at University of California San Diego School of Medicine and Moores Cancer Center used CRISPR technology to identify key regulators of aggressive chronic myeloid leukemia.

UC San Diego Researchers Optimize Microbiome Tool for Computer GPUs

April 17, 2020

UC San Diego researchers have ported the popular UniFrac microbiome tool to graphic processing units (GPUs) to increase the acceleration and accuracy of scientific discovery including urgently needed COVID-19 research.
Category navigation with Social links